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Abstract
Echocardiography is the first-line imaging modality for assessing cardiac function and morphology. The miniaturisation of 
ultrasound technology has led to the development of hand-held cardiac ultrasound (HCU) devices. The increasing sophistica-
tion of available HCU devices enables clinicians to more comprehensively examine patients at the bedside. HCU can augment 
clinical exam findings by offering a rapid screening assessment of cardiac dysfunction in both the Emergency Department and 
in cardiology clinics. Possible implications of implementing HCU into clinical practice are discussed in this review paper.
Keywords Hand-held cardiac ultrasound · Left ventricular ejection fraction · Wall motion abnormality · Left ventricular 
hypertrophy · Valvular heart disease · Jugular venous pressure
Introduction
Historically, the cardiovascular history and examination 
were the primary methods for screening cardiovascular dis-
ease. The advent of hand-held cardiac ultrasound (HCU) 
enables augmentation of the cardiovascular assessment at 
the bedside. These HCU devices enable subjective and quan-
titative assessment of cardiac morphology and function with 
reasonable diagnostic accuracy, even when used by inexpe-
rienced operators with basic training [1–5].
Echocardiography remains the first-line imaging test for 
the assessment of suspected cardiac pathology. Standard 
transthoracic echocardiogram (TTE) allows the determina-
tion of cardiac dysfunction by assessing LV cavity size, wall 
thickness, valvular appearance, and function, as well as for 
the presence of abnormal blood flow within the heart [6]. 
HCU technology is rapidly advancing. These devices may 
ultimately bridge the gap between physical examination and 
TTE, allowing for more rapid clinical decision-making and a 
reduction in the rate of unnecessary TTE referrals.
In this comprehensive review, we aim to provide clini-
cians with a greater understanding of handheld ultrasound 
probe specifications and discuss the clinical utility of HCU 
for the augmentation of the physical cardiovascular examina-
tion. Devices available at the authors’ institution were used 
to acquire images included in the current review.
Available HCU hardware and specifications
Multiple HCU devices are currently approved for clini-
cal use and widely available including Clarius wireless 
scanner (Clarius, Canada), Lumify (Philips, USA), Vscan 
extend (General Electric, USA) and Butterfly iQ (Butterfly 
Network, USA) (Fig. 1). The Lumify device is not avail-
able at our institution and therefore images from this HCU 
device have not been included. All these devices can acquire 
images in B-mode, M-mode and colour Doppler. However, 
each scanner has different capabilities and specifications 
(Tables 1, 2). A comprehensive set of images, including 
pulse-wave Doppler of mitral inflow performed using Clar-
ius PA HD in a healthy individual is shown in Fig. 2.
Currently available HCU devices are designed to be port-
able and lightweight whilst maintaining high technical speci-
fications. The Butterfly iQ device is manufactured using a 
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Fig. 1  Comparison of main handheld echocardiographic systems available. PLAX parasternal long axis, PSAX parasternal short axis, A4C apical 
4-chamber, CD colour Doppler
Table 1  HCU hardware and specifications
Specifications HCU device
Butterfly iQ Philips Lumify GE Vscan extend Clarius C3 HD
Country USA USA USA Canada
Dimensions and weight 144 × 53 × 26 mm C5-2 curved array (135 g) Display unit 
(168 × 76 × 22 mm, weight 
321 g)
164 × 78 × 38 mm
313 g L12-4 linear array (108 g) Dual probe 
(129 × 39 × 28 mm, 120 g)
392 g
S4-1 phased array (96 g)
Price ~ £1699 + £360/year ~ $1200/6 − $ ~ 3360/24 months ~ €4250 − ~ €5100 + Tax ~ £4050
1-year warranty 5 years warranty 1–3 years warranty 3 years warranty
Probe Single probe (3 in 1) 3 probes (curved C5-2, linear 
L12-4, phased S4-1)
Dual probe (linear and sector) Single probe
CMUT/CMOS based Waterproof
Cable USB cable USB cable USB cable Bluetooth and Wi-Fi
Compatibility IOS, Android Android GE Vscan display IOS, Android
Data storage DICOM PACS DICOM PACS DICOM PACS DICOM PACS
Cloud storage Cloud storage Cloud storage Cloud storage
Battery 120 min (2 continuous hours) Continuous scan time of 
60 min
Scan time: ~ 60 min
5 h (for full recharge) 90 min and recharged in 
75 min
Charge time: ~ 90 min
Wireless charging Exchangeable batteries for 
longer scan time
Standby: ~ 7 days
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complementary metal-oxide semiconductor (CMOS) mate-
rial which allows mass production at a low cost, making 
this scanner one of the most affordable. HCU devices are 
compatible with Android, Android-like and iOS devices. 
Images can therefore be interpreted remotely by experienced 
diagnosticians. This includes utilisation in rural areas and 
low-resource countries where conventional ultrasound is not 
easily accessible [7, 8]. Devices also offer Tele-Guidance 
Table 2  HCU clinical imaging 
and artificial intelligence 
specifications
HCU hand-held cardiac ultrasound, 2D 2-dimensional, CDI colour Doppler imaging, PDI power Doppler 
imaging, PWD pulse-wave Doppler
Specification Functions HCU device






Imaging 2D √ √ √ √
M-mode √ √ √ √
CDI √ √ √ √
PDI √ x x √
PWD x x x √
Midline √ x x √
Measurements √ x √ √
Scan depth (cm) 30 30 24 40
Imaging presets (n) 20 10 15 8
Artificial Intelligence Ejection fraction calculator √ x √ x
Tele-guidance √ √ x √
Auto optimise x √ √ √
Bladder volume tool √ x √ x
Apps from GE marketplace x x √ x
Fig. 2  Comprehensive cardiac examination by Clarius PA HD. 
B-mode, colour Doppler and M-mode are demonstrated in paraster-
nal views. In apical views, similar views and pulse wave Doppler 
for mitral inflow are demonstrated. V1 = peak early filling velocity, 
V2 = peak late filling velocity
 Journal of Echocardiography
1 3
allowing live directions from a remote ultrasound expert 
when obtaining and interpreting images. The Clarius ultra-
sound scanner has the unique advantage of being wireless 
making the device more accessible. During the Coronavirus 
disease 2019 (COVID-19) pandemic, HCU has increased in 
popularity due to its safety as the size of the devices makes 
them easier to disinfect compared to standard echocardiog-
raphy machines [9].
The ultrasound technology incorporated into HCU 
devices is becoming increasingly more sophisticated. GE 
Vscan and Butterfly iQ have developed technology to auto-
matically calculate left ventricular ejection fraction whilst 
Clarius ultrasound scanner is the only HCU device able to 
provide pulsed-wave Doppler technology. Butterfly iQ have 
introduced an educational view guidance tool that assesses 
the quality of the images acquired in real-time to enhance 
scanning technique.
Limitations of HCU devices
Battery life limits the use of HCU and therefore is indicated 
for quick scans. Vscan has an exchangeable battery which 
allows for longer scanning times compared to other devices. 
Continuous imaging can lead to the device freezing to allow 
for cooling which also limits the length of time they can be 
used.
Spectral Doppler technology causes HCU devices to heat 
up more rapidly and is one reason for only a few models 
incorporating these imaging modalities. Clarius is one of 
the only scanners on the market capable of PWD, permitted 
by the installation of a liquid heating device which prevents 
overheating [10]. This feature allows for quantitative assess-
ment of cardiac pathologies including left ventricular filling 
pressures (i.e. diastolic function) calculated by measuring 
the E/A ratio and right ventricular dysfunction. This has the 
potential to offer significant value in the bedside assessment, 
diagnosis and monitoring of patients either with suspected 
or decompensating heart failure. Continuous-wave Doppler 
is also not a readily available feature of HCU devices. This 
modality would allow for quantitative assessment of high 
velocities across valves which could confirm aortic stenosis 
or regurgitation, mitral stenosis or tricuspid regurgitation. 
Currently, clinical suspicion of valvular heart disease or aus-
cultation of murmurs can only be qualitatively assessed by 
the majority of HCU devices using standard B-mode and 
colour-flow Doppler.
The availability of HCU varies between departments, 
institutions and countries. For example, Butterfly is not com-
mercially available in Japan compared to the UK where it 
occupies a large share of the market. Although this review 
aims to describe the range of specifications of individual 
HCU devices, there is little research into the impact of these 
varying specifications on their diagnostic ability.
Clinical applications
Point-of-care ultrasound (POCUS) has rapidly transformed 
over the past two decades beyond the large machines that 
were initially introduced into emergency medicine and 
critical care. The advancement of POCUS technology has 
led to the introduction of more portable, handheld devices 
which are now also used in obstetrics to confirm intrauterine 
pregnancies, rheumatology to image for joint and soft tissue 
injuries and gastroenterology in the diagnosis of appendicitis 
and gallbladder pathology [11]. One of the most common 
indications for POCUS is suspected cardiac pathology. HCU 
is a focused, bedside, point of care examination which, in 
combination with clinical examination, ECG, blood results, 
and standard X-Ray can augment and enhance clinical diag-
nosis of a number of acute cardiac conditions. Positive and 
negative findings should be sought actively and documented 
clearly. Where there is doubt around HCU findings, these 
images should be reviewed by a senior sonographer or car-
diologist. Intervention and treatment should not be com-
menced in cases where there is operator doubt about HCU 
imaging findings. With experience and increased caseload, 
HCU operator diagnostic and imaging skills will improve 
and over time, help provide good clinical data to allow early 
intervention and management of many conditions, aid dis-
charge without need to wait for formal departmental TTE 
as well as help rapidly rule out various cardiac conditions.
LV size and systolic function
Physical signs of impaired LV systolic function often only 
manifest when there is advanced disease. HCU can iden-
tify evidence of declining cardiac function in asymptomatic 
patients allowing for earlier commencement of treatment, 
thus limiting the development of cardiac failure. HCU per-
mits the assessment of left ventricular morphology and 
function by estimating LVEF and detecting regional wall 
motion abnormalities (WMA) [4, 12–14]. These methods 
can yield greater clinical value compared to physical exami-
nation [15]. Auscultation of S3 is rarely found in patients 
with LV systolic dysfunction whilst pulmonary oedema is 
an insensitive sign and may only present when the disease 
is severe [16].
Rapid HCU assessment and identification of regional 
WMAs may help confirm a diagnosis of acute myocardial 
infarction (MI) in patients with chest pain who have an 
equivocal or non-localising ECG and/or indeterminate lab-
oratory markers [17]. HCU may also offer initial estimates 
of baseline LV function following MI [18]. Assessment of 
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LV function and presence of LV thrombus after myocardial 
infarction, especially anterior ST-segment elevation myocar-
dial infarction, is important for both treatment and prognos-
tic considerations. Detection of poor LV systolic function 
favours a diagnosis of heart failure (HF) instead of pneumo-
nia or chronic obstructive disease exacerbation in patients 
presenting with non-specific symptoms. This subgroup of 
patients could subsequently benefit from earlier referral for 
further imaging and potentially avoid unnecessary tests. The 
impact of valvular disease on cardiac function can be quanti-
fied by estimating LVEF. Periodic repeat assessment using 
HCU may be able to give an indication of advancing disease 
severity. These assessments can be conducted by specialist 
nurses in outpatient clinics or in the community providing 
potential detection of worsening function and referral to TTE 
before the patient becomes symptomatic [19–21]. Concur-
rent assessment of left ventricular hypertrophy (LVH) and 
LV dilatation when evaluating LV function can help grade 
the severity of cardiac disease or confirm clinical suspicions 
when individual findings are ambiguous.
LV diastolic assessment
Routine TTE examination for LV filling pressure involves 
tissue Doppler imaging (TDI) to measure LV myocardial 
velocities (eʹ and aʹ), pulse-wave Doppler for mitral inflow 
velocities (E and A) and continuous-wave Doppler for meas-
uring peak TR velocity. Current probes do not offer all these 
ultrasound technologies, hence LV diastolic assessment is 
limited to mitral inflow assessment by some probes which 
offer pulse-wave Doppler assessment. Nevertheless, left 
atrial size can be estimated by HCU and this is also routinely 
advocated for estimating LV filling pressures.
Left atrial assessment
Left atrial assessment can be made easily by apical 4-cham-
ber and 2-chamber views. These views are relatively simple 
to acquire by HCU. These views allow us to quantify both 
the left atrial area and volume. HCU can more sensitively 
detect left atrial enlargement compared with auscultation of 
S4 on clinical examination [14, 22–25]. Grading severity of 
mitral valve disease can be aided by measuring the diameter 
of the left atrium. Repeat imaging can assess the response to 
intervention post-surgery.
Valvular heart disease assessment
Quantitative assessment of valvular heart disease (VHD) 
using HCU is limited because pulse-wave and continuous-
wave Doppler modalities are not available with the majority 
of probes. Imaging for valvular insufficiencies or morpho-
logical abnormalities of stenotic valves, therefore, relies on 
qualitative colour-Doppler and B-mode assessment. Ini-
tial assessment following a clinical suspicion of VHD can 
determine whether the patient requires further investigation. 
Repeat imaging can also provide complementary informa-
tion to clinical examination regarding disease progression, 
which can support a decision to refer for more complex 
imaging.
Right ventricular size and function
Early detection of right ventricular (RV) enlargement and 
hypokinesis can improve the prognosis of acutely unwell 
patients such as those admitted with an undiagnosed pulmo-
nary embolism (PE). The majority of fatal PEs occur within 
the first few hours of developing symptoms, with 30–50% 
remaining undiagnosed until autopsy [26, 27]. Rapid and 
accurate assessment of the RV using HCU can lead to a 
more efficient diagnosis, administration of treatment and 
improved prognosis, as findings can necessitate the urgent 
results of tests such as D-dimer in high-risk patients. RV 
end-diastolic diameter has been shown to be the most sen-
sitive predictor of PE which can be measured using HCU. 
Subjective measures including hypokinesis and McConnell’s 
sign of free wall dyskinesia show poor sensitivity for the 
diagnosis of PE. Tricuspid annular plane systolic excursion 
shows reasonable sensitivity and could be measured using 
the M-mode modality of HCU devices. TTE does allow for 
quantitative assessment of RV dysfunction by measuring the 
tricuspid regurgitant jet velocity. This is almost exclusive 
to TTE as it requires continuous-wave Doppler [28, 29]. 
Estimates of systolic pulmonary arterial pressure (sPAP) to 
detect pulmonary arterial hypertension (PAH) have shown 
only moderate diagnostic accuracy when performed using 
HCU devices capable of CWD [18, 30, 31]. Low thresholds 
for bedside HCU assessment of patients with non-specific 
signs and symptoms may allow for earlier TTE referral and 
diagnosis of PAH, which is commonly only diagnosed at an 
advanced stage [32].
Pericardial disease
The presence of an anechoic space within the pericardium, 
right atrial inversion or right ventricular diastolic collapse 
indicates pericardial effusion. These measurements using 
HCU can specifically predict pericardial effusions [14, 18, 
33]. One limitation includes epicardial fat being misinter-
preted as an effusion, especially when the operator is less 
experienced. Assessing respiratory variation of the mitral 
or tricuspid inflow velocities and the aortic flow velocity is 
limited to pulse-wave Doppler probes. Few HCU devices 
can offer this function whilst TTE routinely examines these 
entities allowing for quantitative assessment of pericardial 
disease. Assessment for pericardial fluid or tamponade in 
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patients with myocardial infarction, myocarditis and peri-
carditis are important to guide investigation, therapy and 
discharge planning.
Haemodynamic assessment
Ultrasound examination of jugular venous pressure (U-JVP) 
can be used to estimate a patient’s fluid status by identify-
ing the collapse point of the internal jugular vein (IJV). The 
collapse point is viewed in the longitudinal axis with the 
patient positioned in a semi-upright position (Fig. 3). The 
location of the jugular venous pulsations is highly subjective 
and accuracy of the physical examination varies significantly 
between clinicians [34]. HCU removes this subjectivity 
and can be easily viewed even by inexperienced operators. 
U-JVP allows visualisation of the venous collapse which 
would otherwise be undetectable by a physical examination 
in obese patients. However, U-JVP has limitations as esti-
mates of fluid status become less specific in hypovolaemic 
patients [35]. In an emergency setting, the patient may be 
required to lie supine. In this scenario, U-JVP would not be 
viable and imaging of inferior vena cava (IVC) diameter and 
collapsibility would be required to estimate fluid status. IVC 
assessment in the subcostal view is the standard non-inva-
sive bedside imaging method for estimating haemodynamic 
status. A greater amount of training to achieve basic compe-
tence in IVC image acquisition may be required compared to 
simple imaging of the jugular venous collapse point. How-
ever, IVC diameter and collapsibility can give a quantitative 
measure of fluid status and once sufficiently trained, sensi-
tivity of the technique can reach up to 93% by experienced 
cardiologists [13]. In contrast, the accuracy of the height of 
the collapsing jugular vein above the right atrium as a meas-
ure of fluid status has been variably reported and may best be 
used as a simple, quick-look, qualitative assessment [35, 36].
Training
Minimal training is required to gain basic competency in 
image acquisition using HCU [33]. Although 20–30 scans 
have been deemed acceptable to develop basic skills in ultra-
sound, accurate and reliable interpretation of images requires 
repeated exposure over a prolonged period of time [37]. The 
ability of images to be stored enables less experienced opera-
tors to request interpretation by more senior colleagues. This 
can limit the number of false-positive results which com-
monly occur among inexperienced users, especially when 
only having undertaken limited training [38]. Experience has 
been repeatedly shown to impact the diagnostic accuracy of 
HCU examinations. Level II/III echocardiographers are able 
to more accurately diagnose cardiac pathology compared 
to inexperienced operators with limited echocardiography 
training [33, 39–41]. This suggests that standard echocar-
diography training is fundamental to competently acquire 
and interpret images, as opposed to training solely with an 
HCU device. Positive results need to be interpreted with 
caution, especially when performed by inexperienced HCU 
users. Clinical decision-making should not be solely guided 
by the interpretation of HCU images, even by experienced 
echocardiographers. Instead, HCU should act as an initial 
diagnostic test to aid decision-making on whether further 
investigation including TTE and treatment is required.
The lack of a designated HCU training pathway, certi-
fication and hospital service poses a barrier to the imple-
mentation of bedside imaging in clinical practice. Levels 
of competence cannot be standardised and the absence of 
HCU services means clinicians cannot gain the experience 
necessary to acquire and interpret images with consistently 
high accuracy. Ultrasound education has been implemented 
in American medical school curriculums for more than a 
decade which is currently not available in the UK [42]. Such 
Fig. 3  Ultrasound-measured jugular venous pressure imaged in a 
semi-recumbent position. Top: transverse view of a collapsed IJV. 
The green arrow points towards the collapsed IJV. Bottom: longitudi-
nal axis of the IJV. The IJV tapers until reaching the point of collapse. 
The red arrow indicates the point at which the vein is collapsed. CCA 
common carotid artery, IJV internal jugular vein
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training aids students’ understanding of clinical anatomy and 
development of basic ultrasound skills as well as their diag-
nostic ability [5, 43]. However, this relies on sufficiently 
trained tutors being available which may incur geographical 
bias between schools. HCU services must also be available 
upon graduation to maintain their level of skill.
Cost‑effectiveness
HCU has been associated with reduced costs when com-
pared with standard echocardiography [15, 44, 45]. Verifi-
cation of clinical exam findings using HCU means that the 
rate of unnecessary TTE referrals could be reduced [15]. It is 
important to stress that HCU does not replace TTE and any 
abnormal or uncertain findings should be confirmed with 
further imaging. An increase in the use of HCU imaging 
could lead to a paradoxical increase in TTE referrals due to a 
rise in the number of incidental findings. The use of HCU by 
community nurses may enable further savings by monitoring 
patients with HF. This could allow for earlier detection of 
advancing disease, reducing the risk of further complica-
tions and need for more complex interventions. A substantial 
potential cost relates to the implementation of HCU services 
and provision of the appropriate training. Restructuring of 
the standard echocardiography pathway and development of 
standardised levels of competency are required to integrate 
HCU into routine practice, which has complex logistical and 
financial implications.
Conclusion
The increasing sophistication of available HCU devices ena-
bles clinicians to more comprehensively examine patients 
at the bedside. HCU can augment clinical exam findings by 
offering a rapid screening assessment of cardiac dysfunction 
in both the Emergency Department and in cardiology clin-
ics. Possible implications of implementing HCU into clini-
cal practice are earlier detection of cardiac pathology and a 
reduction in unnecessary TTE referrals.
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